Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,895 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Original research: Low molecular weight heparin synergistically enhances the efficacy of adoptive and anti-PD-1-based immunotherapy by increasing lymphocyte infiltration in colorectal cancer (2023-08-18)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: -
Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment (2023-11-01)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: Hank's Balanced Salt Solution (HBSS), with calcium, magnesium, without phenol red, Penicillin-Streptomycin Solution, 100 ×, Human Umbilical Vein Endothelial Cells -
Original research: Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination (2023-12-01)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: -
Original research: CXCL10 and Nrf2-upregulated mesenchymal stem cells reinvigorate T lymphocytes for combating glioblastoma (2023-12-06)
Journal: Journal for ImmunoTherapy of Cancer (2023) IF: 10.9Products Cited: Mouse Bone Marrow Mesenchymal Stem cells, GL261 Cells Line -
Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate (2023-01-14)
Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023) IF: 10.8Products Cited: -
HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy (2023-03-21)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: -
Microneedle-assisted vaccination combined with autophagy regulation for antitumor immunotherapy (2023-04-24)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: -
Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor (2023-09-09)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: -
Negatively charged bladder acellular matrix loaded with positively charged adipose-derived mesenchymal stem cell-derived small extracellular vesicles for bladder tissue engineering (2023-11-18)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8Products Cited: Human Bone Marrow Mesenchymal Stem Cells Adipogenic Differentiation Medium, Rat Bladder Smooth Muscle Cells, Human Bone Marrow Mesenchymal Stem Cells Osteogenic Differentiation Medium, Human Umbilical Vein Endothelial Cells, Human Bone Marrow Mesenchymal Stem Cells Chondrogenic Differentiation Medium -
Inducing in situ M2 macrophage polarization to promote the repair of bone defects via scaffold-mediated sustained delivery of luteolin (2023-12-18)
Journal: JOURNAL OF CONTROLLED RELEASE (2023) IF: 10.8
